scholarly article | Q13442814 |
P356 | DOI | 10.3109/10428194.2010.529204 |
P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.529204 |
P698 | PubMed publication ID | 21077742 |
P2093 | author name string | Wei Zhang | |
Liang Wang | |||
Daobin Zhou | |||
Yongji Wu | |||
Dachun Zhao | |||
Quancai Cui | |||
P2860 | cites work | The biology of VEGF and its receptors | Q27860704 |
Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
The current status of lymphoma classification | Q33940248 | ||
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression | Q35835003 | ||
Macrophages and the hypoxic tumour microenvironment | Q36813993 | ||
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis | Q37398320 | ||
Tumor-associated macrophages as targets for tumor immunotherapy. | Q37773280 | ||
High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. | Q46845329 | ||
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi. | Q48608139 | ||
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas | Q61641369 | ||
Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach | Q73276399 | ||
[The 2008 WHO lymphoma classification] | Q79788213 | ||
Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab | Q81189195 | ||
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis | Q82782774 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | peripheral T-cell lymphoma | Q7168693 |
P304 | page(s) | 46-52 | |
P577 | publication date | 2010-11-15 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified | |
P478 | volume | 52 |
Q33408536 | Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). |
Q38388719 | CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas |
Q38097963 | Carcinoma-associated fibroblasts, its implication in head and neck squamous cell carcinoma: a mini review |
Q99211990 | Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas |
Q37662219 | GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma |
Q83133759 | High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma |
Q40174970 | High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma |
Q40922483 | High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type |
Q84075664 | High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas |
Q39070526 | Hypoxia-related gene expression profile in childhood acute lymphoblastic leukemia: prognostic implications |
Q44328764 | Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis |
Q35029454 | Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells |
Q44861189 | Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma |
Q92981904 | Mutual editing of alternative splicing between breast cancer cells and macrophages |
Q28072045 | New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy |
Q94570254 | Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16-/CD16 + monocyte ratio |
Q53148664 | Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy. |
Q39978774 | Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma |
Q36284948 | Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes |
Q33632109 | TIE-2 expressing monocytes in human cancers. |
Q38581916 | The role of alisertib in treatment of peripheral T-cell lymphomas |
Q38391574 | VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma evidence from a systemic meta-analysis |